Inbrija (levodopa) is a brand-name inhaler prescribed for Parkinson’s disease. The cost of the drug, with and without insurance, can depend on several factors, such as whether Inbrija has a savings ...

Acorda Therapeutics has launched a streaming commercial for Inbrija, a four-year-old rescue inhaler for Parkinson’s sufferers, delivered only to viewers who have self-identified as being impacted in ...

PEARL RIVER, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced the submission of new regulatory filings for the approval of INBRIJA ® (levodopa inhalation powder) in six ...

ARDSLEY, N.Y. & PANAMA CITY--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) and Biopas Laboratories today announced that they have entered into distribution and supply agreements to ...